San Diego, CA, United States of America

Amy L Cavalli

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Lpath, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amy L Cavalli. Retrieved from https://idiyas.com/inventor/amy-l-cavalli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Amy L. Cavalli

Introduction

Amy L. Cavalli is a notable inventor based in San Diego, California. She has made significant contributions to the field of medicine, particularly in the treatment and prevention of hyperproliferative diseases. With one patent to her name, her work reflects a commitment to advancing healthcare solutions.

Latest Patents

Amy L. Cavalli holds a patent for "Compositions and methods for the treatment and prevention of hyperproliferative diseases." This patent describes monotherapies and combination therapies aimed at treating hyperproliferative disorders. The compositions outlined in her patent are designed to perform these innovative methods effectively.

Career Highlights

Cavalli is associated with Lpath, Inc., where she applies her expertise in developing therapeutic solutions. Her work at the company showcases her dedication to improving patient outcomes through innovative medical treatments.

Collaborations

Throughout her career, Amy has collaborated with esteemed colleagues such as Roger A. Sabbadini and William A. Garland. These partnerships have likely contributed to the advancement of her research and the successful development of her patented methods.

Conclusion

Amy L. Cavalli's contributions to the field of medicine through her innovative patent demonstrate her commitment to addressing critical health challenges. Her work continues to inspire advancements in the treatment of hyperproliferative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…